Federal Register of Legislation - Australian Government

Primary content

PB 88 of 2021 Other as made
This instrument amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015) to add, delete and alter listed pharmaceutical items and associated periods and circumstances.
Administered by: Health
Registered 31 Aug 2021
Tabling HistoryDate
Tabled HR01-Sep-2021
Tabled Senate02-Sep-2021
To be repealed 11 Feb 2022
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Table of contents.

Commonwealth Coat of Arms of Australia

 

PB 88 of 2021

 

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2021
(No. 8)

 

National Health Act 1953

 

I, NIKOLAI TSYGANOV, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health and Aged Care, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated               27 August 2021

 

 

 

 

 

NIKOLAI TSYGANOV

Assistant Secretary (Acting)

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

 

 


Contents

1......... Name............................................................................................................................... 1

2......... Commencement............................................................................................................... 1

3......... Authority......................................................................................................................... 1

4......... Schedules......................................................................................................................... 1

Schedule 1—Amendments                                                                                                                          2

National Health (Pharmaceutical benefits—early supply) Instrument 2015
(PB 120 of 2015).
                                                                                                                                   2

 

 

 

 

 


1  Name

(1)          This instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2021 (No. 8).

(2)          This Instrument may also be cited as PB 88 of 2021.

2  Commencement

(1)          Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1. The whole of this instrument

1 September 2021

1 September 2021

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)          Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

This instrument is made under subsection 84AAA(2) of the National Health Act 1953.

4  Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.


Schedule 1Amendments

National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015)

[1]        Schedule 1, entry for Metformin

omit:

 

Tablet (prolonged release) containing metformin hydrochloride 500 mg

20

120

5

 

[2]        Schedule 1, after entry for Norethisterone with mestranol

insert:

Obeticholic acid

Tablet 5 mg

20

30

5

 

 

Tablet 10 mg

20

30

5

 

[3]        Schedule 1, entry for Trihexyphenidyl

omit:

 

Tablet containing trihexyphenidyl hydrochloride 2 mg (USP)

20

200

2

 

[4]        Schedule 1, after entry for Varenicline in the form Tablet 1 mg (as tartrate)

insert:

Vedolizumab

Injection 108 mg in 0.68 mL single use pre-filled pen

20

2

0

 

 

 

20

2

5